top of page


We are developing drug candidates with special emphasis on reopening cortical plasticity, which can be applied to various brain diseases and cognition enhancement.

Evaluation of drug efficacy on synaptic function by measuring EPSCs at Schaffer collateral - CA1 circuit from acute hippocampal slices in Alzheimer’s disease animal model

bottom of page